Clinical utility of circulating tumour DNA (ctDNA) in resectable gastric cancer (GC)ANNALS OF ONCOLOGYIF65.42020-11-015OAAI
Meta-analyses on mutation status concordance between tumor tissue and circulating tumor DNA and prognostic value of ctDNA in pancreatic cancerANNALS OF ONCOLOGYIF65.42020-07-010OAAI
Clinical utility of circulating tumor DNA in resectable and advanced pancreatic cancerANNALS OF ONCOLOGYIF65.42020-07-011OAAI
The comparison of mFOLFOX-6, mDCF, mFOLFIRINOX in the first-line treatment of advanced gastric cancerANNALS OF ONCOLOGYIF65.42020-07-010OAAI
IGM AUTOANTIBODIES AGAINST LIPOPROTEIN(A) AS AN ANTI-ATHEROGENIC FACTOR IN PATIENTS WITH SEVERE HYPERLIPIDEMIAATHEROSCLEROSISIF5.72018-08-010PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向